Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
GENEVA, SWITZERLAND - EQS Newswire - 15 December 2025 - MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company) announced today the completion of its business combination with NeuroX Group SA (NeuroX), a commercial-stage company delivering evidence-based, precision digital treatments for neurological diseases.




